This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: University of California. Active years: 2009-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Los Angeles, CA (US) (2009 - 2012)
- Kingston, RI (US) (2011 - 2014)
Company Filing History:
Years Active: 2009-2014
Title: Innovator Navindra P. Seeram: Pioneering Research in Therapeutic Applications of Urolithins
Introduction
Navindra P. Seeram is an accomplished inventor based in Los Angeles, CA, whose innovative contributions to the field of medical science have resulted in a total of five patents. His work primarily focuses on the therapeutic uses of ellagitannin metabolites, specifically urolithins, in the treatment and prevention of neoplastic diseases.
Latest Patents
Seeram's latest patents are centered around the therapeutic applications of urolithins. The subject invention highlights how ellagitannin metabolites, such as urolithin, can be utilized in treating or preventing neoplastic diseases in subjects. This research presents significant potential for advancements in cancer therapeutics, opening new avenues for medical treatment.
Career Highlights
Navindra P. Seeram is affiliated with the University of California, where he leverages his expertise to further the understanding of phytochemicals and their benefits in human health. His dedication to research and innovation has positioned him as a key figure in the exploration of natural compounds for therapeutic use.
Collaborations
In his endeavors, Seeram collaborates closely with David Heber, a respected colleague in the field. Together, they contribute to the advancement of knowledge in nutrition and health, ensuring impactful discoveries that could revolutionize treatment methodologies.
Conclusion
Navindra P. Seeram's work exemplifies the spirit of innovation in the scientific community. Through his patented research on urolithins, he is paving the way for novel therapeutic solutions, significantly impacting the field of cancer treatment. As he continues his mission at the University of California, his contributions remain critical to understanding and harnessing the power of natural compounds for human health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
